Risk assessment method, device and storage medium for post-ERCP pancreatitis

By inputting the patient's case information into the trained pancreatitis risk assessment model and using algorithms such as decision trees and random forests for evaluation, the problem of inability to obtain the patient's pancreatitis risk in advance before ERCP operation is solved, and pancreatitis risk assessment is achieved before and during ERCP operation, improving the accuracy and safety of diagnosis and treatment.

CN114267453BActive Publication Date: 2025-03-28WUHAN UNIV
2 Cites 0 Cited by

Patent Information

Application Number
CN202210128830.7
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2022-02-11
Publication Date
2025-03-28
Estimated Expiration
2042-02-11

AI Technical Summary

Technical Problem

The risk of postoperative pancreatitis of ERCP is not available in advance before ERCP operation, resulting in limited clinical application of ERCP.

Method used

By obtaining the case information of the target patient and inputting it into the trained pancreatitis risk assessment model, and using algorithms such as decision trees and random forests for evaluation, the patient's pancreatitis risk score was obtained.

Benefits of technology

It is achieved to obtain the results of patients' pancreatitis risk assessment before ERCP surgery, avoid ERCP surgery on high-risk patients, and evaluate the risk of pancreatitis in real time during ERCP surgery, which improves the accuracy and safety of diagnosis and treatment.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

The present invention discloses a method, device and storage medium for risk assessment of pancreatitis after ERCP. The method comprises obtaining case information of a target patient, inputting the case information of the target patient into a trained pancreatitis risk assessment model, and obtaining a pancreatitis assessment result of the target patient. By adopting the embodiment of the present invention, not only can the pancreatitis assessment result of the target patient be known before ERCP, thereby avoiding ERCP surgery on high-risk patients, but also the risk of pancreatitis can be assessed in real time during ERCP according to the case information of the target patient, thereby realizing the automation of risk assessment of pancreatitis and providing a reliable basis for doctors to perform ERCP and related preventive treatments.
Need to check novelty before this filing date? Find Prior Art